DREAMM-9 #EHA2026: Belamaf 1.9mg/kg Q8W BVRd hits ORR 96%, ≥CR 88%, MRD- 54% in transplant-ineligible NDMM. Extended intervals (→Q12W) resolve ocular AEs in 100%. Optimal dose confirmed for DREAMM-10. Efficacy meets manageability. 🔥 #MultipleMyeloma #mmsm

En Rosario a la Avenida Pte. Perón muchos le seguimos diciendo Godoy, al igual q la continuación al Oeste de calle Eva Perón desde Bvrd. Avellaneda quienes la seguimos llamando Córdoba, xq hacia allí se dirige desde siempre...

Recibilo en tu casa, en la cede del PN, en la casa de los Lamas o en la cruz de Bvrd. Artigas pero se dejan de estar metiendo al catolicismo en el parlamento. Referencia para ud.. Art. 5 de la constitución, si no se invitan a jefes de Estado, por qué debería ir el Papa.

CONGRESS | #EHA2026 | PRESENTATION Enrique Ocio presents final results from the phase I DREAMM-9 study evaluating the optimal dose and schedule of belantamab mafodotin plus bortezomib, lenalidomide, and dexamethasone (BVRd) for the treatment of transplant-ineligible NDMM (N = 118). The highest response rates were observed with Q6/8W dosing (ORR, 96%; ≥CR, 88%; MRD negativity, 54%). Within the Q6/8W cohorts, induction with belantamab mafodotin 1.9 mg/kg resulted in deeper responses than the 1.4 mg/kg dose (≥CR, 92% vs 83%). Extended dosing intervals were associated with fewer Grade ≥3 ocular AEs; 86% of first events resolved with Q6/8W dosing, and 100% resolved with Q9/12W and Q12W dosing. These data support the use of belantamab mafodotin 1.9 mg/kg Q8W for 24 weeks, followed by Q12W dosing, in the DREAMM-10 and PrE1005 studies. Follow our live feed for more updates: loom.ly/CXccZxs Intended for HCPs only. This congress coverage is independently supported by pharmaceutical companies, who are allowed no influence on the content; a full list of supporters can be found on our website. #MultipleMyeloma #myeloma #mmsm #MedEd

BVRD Brick By Brick Collection Available Now 👁️🧱 All sizes S - 2XL On Hand & Ready To Ship‼️ 🚨 Receive 10% OFF your first order when you sign up for SMS & Email updates.🚨 Limited quantities. No restocks.⚠️ BVRDOFFICIAL.COM #BrokeVisionsRichDreams #ExplorePage

Built From Pressure, Not Permission BVRD “Brick By Brick” Collection Out Now🧱 All Sizes S - 2 XL Available *All Sets Are Pre-Made And Ready To Ship* To Shop Click The Link In Bio‼️ bvrdofficial.com #BrokeVisionsRichDreams #ExplorePage

One of the biggest questions surrounding belantamab mafodotin in multiple myeloma has never been whether it works. It's been how to harness its potency while minimizing ocular toxicity. The DREAMM-9 study offers an important clue. Investigators explored multiple dosing schedules of belantamab combined with bortezomib, lenalidomide, and dexamethasone (BVRd) in transplant-ineligible newly diagnosed multiple myeloma, asking a deceptively simple question: Can we separate efficacy from toxicity through smarter scheduling? The answer appears to be yes. Across all dosing cohorts, response rates exceeded 83%. More intensive induction schedules produced the deepest responses, with up to 75% of patients achieving complete response or better and 55% reaching MRD negativity. But there was a tradeoff. Higher-dose intensity schedules also led to substantially more ocular findings, including keratopathy and vision-related side effects. The most intriguing finding emerged when investigators adjusted the strategy: hit hard early, then ease off. Patients receiving higher belantamab exposure during induction followed by less frequent maintenance dosing maintained strong responses while experiencing improved tolerability, fewer severe ocular events, and better vision-related quality-of-life outcomes. In many ways, DREAMM-9 is a study about balance. Not simply whether a drug works, but how to deliver the right dose at the right time to maximize benefit while preserving quality of life. As belantamab continues its resurgence in multiple myeloma, these data suggest that schedule optimization may be just as important as the drug itself. Sometimes the future of cancer therapy isn't a new treatment—it's learning how to use a powerful one more intelligently. asco.org/abstracts-presentat…

DREAMM-9 final analysis: Belamaf VRd (BVRd) shows promising outcomes in transplant-ineligible newly diagnosed multiple myeloma (#NDMM). A potential step forward in frontline myeloma care. #ASCO26 #MultipleMyeloma Always believed dose optimization is a long process and kudos to @szusmani and team along with @GSK for being persistent and tryping to find best dose. This is am important drug, especially with no CRS/ICANS etc, and key in community practices. Glad to see @precog helping in this efforts #MMSM #ASCO2026

CONGRESS | #ASCO2026 | PRESENTATION Saad Usmani presents findings from the phase I DREAMM-9 study evaluating belantamab mafoditin bortezomib lenalomide dexamethasone (BVRd) in transplant ineligible patients with ND MM (N = 118). The ORRs were 90%, 96%, and 85% in the Q3/4W, Q6/8W, and Q9/12W cohorts, respectively. Grade 3 or high ocular events occurred in 74%, 88%, and 35% of patients in the Q3/4W, Q6/8W, and Q9/12W cohorts, respectively. Extended dosing schedules were not associated with significant deterioration in VRF compared with more frequent dosing schedules. Follow our live feed for more updates: multiplemyelomahub.com/medic… Intended for HCPs only. This congress coverage is independently supported by pharmaceutical companies, who are allowed no influence on the content; a full list of supporters can be found on our website. #mmsm #myeloma @MSKCancerCenter @szusmani

Join MSK myeloma specialist @szusmani at #ASCO26 as he presents final results from the DREAMM-9 study evaluating belantamab mafodotin in combination with BVRd for transplant-ineligible patients with newly diagnosed #MultipleMyeloma. 🕒 Friday, May 29 | 3:45 p.m. CDT Learn more: bit.ly/3PSMIIx @ASCO

I’m usually speaking from the US perspective when talking about investing, but for my caricom peeps we have stock exchanges too Jamaica Stock Exchange (JSE) Trinidad and Tobago Stock Exchange (TTSE) Barbados Stock Exchange (BSE) Bahamas International Securities Exchange (BISX) Cayman Islands Stock Exchange (CSX) Bolsa de Valores de la República Dominicana (BVRD) Eastern Caribbean Securities Exchange (ECSE): Headquartered in St. Kitts, it is a fully electronic regional market serving Anguilla, Antigua and Barbuda, Dominica, Grenada, Montserrat, St. Kitts and Nevis, St. Lucia, and St. Vincent and the Grenadines.

💛❤️ BVRD Commission : @Fronggs

Te puedo asegurar que el curso más básico de Abacus (Abacus Experience) es más completo que cualquiera que imparta una institución aquí en RD. Hablo desde la experiencia, ya que he tomado formaciones en ABA y en la BVRD

Y bueno es Rivera y bvrd que pensabas, ahí siempre colapsa en hora pico y si llueve más 🤣

Ce sont des vauriens sans couilles. Ceux qui ont l’habitude de braver les pavés et de lutter au prix de leurs sangs sont les enfants des pauvres. Mais ceux ci st pas disposés à se battre contre ces militaires. Donc coe eux ils aiment la vie plus que leur dignité, ils déversent leurs frustrations sur les gens qui vivent à l’extérieur. Parce que, figure toi, on a pas le droit de leur dire de prendre leur mal en patience. Sinon s’ils sont fâchés ils savent la route du bvrd. Pourtant tu vas partir à bko, leur préoccupation première c’est les femmes. Svt faut pas les repondres. On a de coeur avec tous ceux qui souffrent réellement des problèmes que traversent le pays et Inchallah sa va aller pour eux. Mais on est pas avec des gens qui sont ds la division coe eux la

Los patrulleros chocadores. Una camioneta de la Policía de Santa Fe y un auto particular colisionaron hace instantes en Santa Fe y Bvrd. Avellaneda. El mayor daño lo sufrió el Palio. La zona está con cortes de tránsito.

El trapito usurpa el espacio público. Y en Bvrd. Oroño no tiene razón de existir, entre el río y Pellegrini debe ser la zona más custodiada de la ciudad.

Se viene la segunda función de "WATAFAK!" Miércoles 11 de febrero a las 22. Sala Nachman del @auditoriumrs. Entradas en la boletería del teatro (Bvrd. Marítimo 2280) o por @Plateanet (link en bio). Los espero.

IRL VM was also very dedicated to BVRD 😇 they opened a documentary of their battles before the race, let everyone watch it and ended with Victoria Mile the 5th logo 😂 【ＨＤ】ブエナビスタ強し！（2010年ヴィクトリアマイルＧⅠ） youtu.be/aNywtnBk7I4?si=MGv4… via @YouTube